These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8592904)

  • 21. [Resistance profiles of the various species of the genus Staphylococcus to 15 clinically-used antimicrobials].
    Catalano M; Romeo AM; Ochoa LB
    Rev Argent Microbiol; 1989; 21(3-4):111-9. PubMed ID: 2486210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of Staphylococcus schleiferi from healthy dogs and dogs with otitis, pyoderma, or both.
    May ER; Hnilica KA; Frank LA; Jones RD; Bemis DA
    J Am Vet Med Assoc; 2005 Sep; 227(6):928-31. PubMed ID: 16190591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci].
    Hara T; Araake M; Tsuruoka T; Watabe H
    Jpn J Antibiot; 2003 Apr; 56(2):142-7. PubMed ID: 12825415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canine superficial bacterial folliculitis: current understanding of its etiology, diagnosis and treatment.
    Bloom P
    Vet J; 2014 Feb; 199(2):217-22. PubMed ID: 24345778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [beta-lactamase-producing activity and antimicrobial susceptibility of major pathogenic bacteria isolated from clinical samples. Japan beta-lactamase Research Group].
    Oguri T; Igari J; Hiramatsu K; Watanabe A; Inoue M; Abe M; Yamane N; Aihara M; Hashimoto H;
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():1-28. PubMed ID: 12599526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility of coagulase-positive staphylococci isolated from Louisiana dogs.
    Cox HU; Hoskins JD; Roy AF; Newman SS; Luther DG
    Am J Vet Res; 1984 Oct; 45(10):2039-42. PubMed ID: 6497102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prior antimicrobial use as a risk factor for resistance in selected Staphylococcus pseudintermedius isolates from the skin and ears of dogs.
    Zur G; Gurevich B; Elad D
    Vet Dermatol; 2016 Dec; 27(6):468-e125. PubMed ID: 27870236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antimicrobial susceptibility of Staphylococcus species isolated from canine dermatitis.
    Kruse H; Hofshagen M; Thoresen SI; Bredal WP; Vollset I; Søli NE
    Vet Res Commun; 1996; 20(3):205-14. PubMed ID: 8739519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections.
    Ganière JP; Médaille C; Etoré F
    Res Vet Sci; 2004 Aug; 77(1):67-71. PubMed ID: 15120955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility profiles of Staphylococcus intermedius isolates from clinical cases of canine pyoderma in South Africa.
    Blunt CA; van Vuuren M; Picard J
    J S Afr Vet Assoc; 2013 May; 84(1):E1-6. PubMed ID: 23718758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species distribution and antimicrobial susceptibility of staphylococci isolated from canine otitis externa.
    Penna B; Varges R; Medeiros L; Martins GM; Martins RR; Lilenbaum W
    Vet Dermatol; 2010 Jun; 21(3):292-6. PubMed ID: 20042036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story.
    Richmond MH
    Rev Infect Dis; 1979; 1(1):30-8. PubMed ID: 400938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of Staphylococcus schleiferi from dogs with pyoderma.
    Frank LA; Kania SA; Hnilica KA; Wilkes RP; Bemis DA
    J Am Vet Med Assoc; 2003 Feb; 222(4):451-4. PubMed ID: 12597417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius from dogs.
    Valentine BK; Dew W; Yu A; Weese JS
    Vet Dermatol; 2012 Dec; 23(6):493-e95. PubMed ID: 23050904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elimination of Staphylococcus intermedius in healthy dogs by topical treatment with fusidic acid.
    Saijonmaa-Koulumies L; Parsons E; Lloyd DH
    J Small Anim Pract; 1998 Jul; 39(7):341-7. PubMed ID: 9693420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmission of multiple antimicrobial-resistant Staphylococcus intermedius between dogs affected by deep pyoderma and their owners.
    Guardabassi L; Loeber ME; Jacobson A
    Vet Microbiol; 2004 Jan; 98(1):23-7. PubMed ID: 14738778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prior antibacterial drug exposure in dogs with meticillin-resistant Staphylococcus pseudintermedius (MRSP) pyoderma.
    Hensel N; Zabel S; Hensel P
    Vet Dermatol; 2016 Apr; 27(2):72-8e20. PubMed ID: 26909526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility and methicillin resistance in Staphylococcus pseudintermedius and Staphylococcus schleiferi subsp. coagulans isolated from dogs with pyoderma in Japan.
    Kawakami T; Shibata S; Murayama N; Nagata M; Nishifuji K; Iwasaki T; Fukata T
    J Vet Med Sci; 2010 Dec; 72(12):1615-9. PubMed ID: 20703027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What's happened to Staphylococcus intermedius? Taxonomic revision and emergence of multi-drug resistance.
    Bond R; Loeffler A
    J Small Anim Pract; 2012 Mar; 53(3):147-54. PubMed ID: 22251285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical therapy for drug-resistant pyoderma in small animals.
    Jeffers JG
    Vet Clin North Am Small Anim Pract; 2013 Jan; 43(1):41-50. PubMed ID: 23182323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.